Investor Relations Home

Spotlight Innovation Inc. (OTCQB: STLT) identifies and acquires rights to innovative and proprietary platform technology candidates with a focus on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and unique opportunities.

Access to platform technology candidates is accomplished via our extensive relationships with many leading academic institutions and other sources. We provide value-added development capability and funding in order to accelerate development progress. When commercially significant benchmarks have been achieved, we will partner with proven market leaders via sale, out-license or strategic alliance.

Request Additional Information
Contact us by clicking here.

Investor Relations Firm
CEOcast, Inc.
211 East 43rd Street, 4th Floor
New York, NY 10017
Office: 212-732-4300
rwoods@ceocast.com

STLT
0.348
0.000 (0.00%)


QUICK LINKS


Spotlight Innovation
Company Overview February 2016

Click this link to view the PDF in your browser or right click and “Save As…” to download

Spotlight Innovation Investor/Company Overview

Spotlight Innovation Inc. Updates its Company Overview for Prospective Buyers of its Shares, Investors and Current Shareholders


Analyst Research Reports

April 22, 2016
Zacks Small-Cap Research

January 29, 2016
Zacks Small-Cap Research

November 19, 2015
SeeThruEquity

August 12, 2015
Zacks Small-Cap Research